These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10367599)

  • 21. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.
    Globits S; Frank H; Pacher B; Huelsmann M; Ogris E; Pacher R
    Am Heart J; 1998 Apr; 135(4):592-7. PubMed ID: 9539472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
    Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
    Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
    Lewis BS; Makhoul N; Dakak N; Flugelman MY; Yechiely H; Halon DA; Kahana L
    Am Heart J; 1992 Oct; 124(4):1009-16. PubMed ID: 1388322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
    Franco-Saenz R; Somani P; Mulrow PJ
    Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged hemodynamic benefits from a high-dose bolus injection of human atrial natriuretic factor in congestive heart failure.
    Giles TD; Quiroz AC; Roffidal LE; Marder H; Sander GE
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):557-63. PubMed ID: 1834391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.
    Vesely DL; Dietz JR; Parks JR; Baig M; McCormick MT; Cintron G; Schocken DD
    Circulation; 1998 Jul; 98(4):323-9. PubMed ID: 9711937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide during acute treatment of congestive heart failure.
    Berglund H; Bevegård S; Carlens P; Hedner J; Hedner T
    Clin Physiol; 1988 Apr; 8(2):155-62. PubMed ID: 2966029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure.
    Raya TE; Lee RW; Westhoff T; Goldman S
    Circulation; 1989 Dec; 80(6):1886-92. PubMed ID: 2532077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
    Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
    Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure.
    Riegger GA; Kromer EP; Kochsiek K
    J Cardiovasc Pharmacol; 1986; 8(6):1107-12. PubMed ID: 2434734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure.
    Molina CR; Fowler MB; McCrory S; Peterson C; Myers BD; Schroeder JS; Murad F
    J Am Coll Cardiol; 1988 Jul; 12(1):175-86. PubMed ID: 2967855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives.
    Dessì-Fulgheri P; Sarzani R; Serenelli M; Tamburrini P; Spagnolo D; Giantomassi L; Espinosa E; Rappelli A
    Hypertension; 1999 Feb; 33(2):658-62. PubMed ID: 10024323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.